Skip to main content

Site notifications

Annual charge exemptions (ACE) dataset

View annual charge exemptions (ACE) based on a sponsor declaring $0 turnover.

In order to ensure transparency about the availability of therapeutic goods in Australia, all entries in the ARTG that had not commenced generating turnover and were exempt from annual charges under the ACE scheme in previous financial years, are published on the TGA website annually under the authority of subsection 61 (5C) of the Therapeutic Goods Act 1989.

Exemptions published are for the 2024-2025 financial year.

You can view previous financial years exemptions on Trove.

Last updated
Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Search

20197 result(s) found, displaying 3276 to 3300
  • Exempt from annual charge in 2024-25 due to Olympus Australia Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Medtronic Australasia Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Zimmer Biomet Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Zimmer Biomet Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Zimmer Biomet Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Compliance Management Solutions declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Zimmer Biomet Pty Ltd declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes declaring $0 turnover in that period.
  • Exempt from annual charge in 2024-25 due to Stryker Australia Pty Ltd declaring $0 turnover in that period.
Last updated